Usall i Rodié J
Sant Joan de Déu-Serveis de Salut Mental, Centre de Salut Mental El Prat, Barcelona.
Actas Esp Psiquiatr. 2004 Sep-Oct;32(5):307-13.
Gender-based pharmacology is a new research and clinical area which could be defined by the inclusion of gender-related variables in clinical, research and educational issues with respect to pharmacotherapy. Most of the studies which have studied pharmacokinetic gender differences in psychotropic drugs have found that women tend to have higher plasma concentrations. As regards differences in treatment response, most evidence points to a more rapid response to neuroleptics and lower therapeutic doses in women, and, on the other hand, a possible better response to selective serotonin reuptake inhibitors (SSRI) in premenopausal women. In addition, women appear to have a higher incidence of adverse effects to different psychotropic drugs.
基于性别的药理学是一个新的研究和临床领域,它可以通过在药物治疗的临床、研究和教育问题中纳入与性别相关的变量来定义。大多数研究精神药物药代动力学性别差异的研究发现,女性往往具有较高的血浆浓度。关于治疗反应的差异,大多数证据表明女性对抗精神病药物的反应更快,治疗剂量更低,另一方面,绝经前女性对选择性5-羟色胺再摄取抑制剂(SSRI)可能有更好的反应。此外,女性对不同精神药物的不良反应发生率似乎更高。